장마감
로그인 회원가입
BYSI
BYSI
BeyondSpring Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$1.17
+0.05 ▲ +4.46%
🌙 7월 27일 7:34 PM ET (한국 7/28 08:34)
$1.17
+0.00 +0.00%

비욘드스프링(BYSI) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$48M
스몰캡
P/E
-
배당수익률
없음
52주 위치
12%
저점 +18% · 고점 -52%
애널리스트
매수
C+
Fundamental health
vs. Biotechnology· based on 2 axes
수익성
산출 불가 (적자)
성장
Top 38%
밸류에이션
데이터 부족
재무 안정
Top 57%
Index -P/E -EPS (ttm) -0.19Insider Own 24.14%Shs Outstand 41.1MPerf Week -5.65%
Market Cap 0.05BForward P/E -EPS next Y -Insider Trans -Shs Float 31.2MPerf Month -26.88%
Enterprise Value 0.04BPEG -EPS next Q -Inst Own 5.34%Short Float 7.14%Perf Quarter -31.38%
Income -0.01BP/S -EPS this Y -Inst Trans -1.35%Short Ratio 90.69Perf Half Y -27.78%
Sales 0.00BP/B -EPS next 5Y -ROA -29.48%Short Interest 2.23MPerf YTD -28.22%
Book/sh -0.84P/C 6.12EPS past 3/5Y 38.52% 37.25%ROE -52W High -52.05% ($2.44)Perf Year -39.06%
Cash/sh 0.19P/FCF -Sales past 3/5Y -ROIC -52W Low 17.71% ($0.99)Perf 3Y 14.71%
Dividend Est. -EV/EBITDA -EPS Y/Y TTM 52.82%Gross Margin -Volatility(W/M) 9.12% 9.33%Perf 5Y -87.37%
Dividend TTM -EV/Sales -Sales Y/Y TTM -Oper. Margin -ATR (14) 0.12Perf 10Y -
Dividend Ex-Date -Quick Ratio 1.09EPS Q/Q 15.59%Profit Margin -RSI (14) 33.23Recom 2
Dividend Gr. 3/5Y -Current Ratio 1.09Sales Q/Q -SMA20 -18.75% ($1.44)Beta 0.51Target Price $1.25
Payout -Debt/Eq -Earnings 2026/3/25SMA50 -23.94% ($1.54)Rel Volume 0.4Prev Close $1.12
Employees 44LT Debt/Eq -EPS/Sales Surpr. -SMA200 -29.84% ($1.67)Avg Volume(3M) 0.02MPrice $1.17
IPO 2017/3/9Option/Short Yes/YesTrades 89Volume 9,769Change 4.46%
Quarterly earnings trend SEC filings · USD
21.9
24.3
24.6
24.9
25.3
25.6
25.9
26.3
Revenue Net income 최근 분기: 매출 - · 순이익 $-2M (YoY -148%)

📊 BeyondSpring Inc (BYSI) Investment Analysis

What kind of company is BeyondSpring Inc?

비욘드스프링(BYSI) 방어주
Healthcare · Biotechnology
Small-Cap — Low Volume, High Volatility

🧬 A global clinical-stage biotech company challenging the new standard of care in lung cancer treatment through 'Plinabulin,' which simultaneously induces immunotherapy and cancer cell death.

Learn more about BeyondSpring Inc →
Market Cap
$0.0B
Approx. KRW 0.1 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank4935
Employees44people
IPO2017/03/09
Current Price$1.17 ≈ 1,603원
NASD · USA

Key Events

⏰ Upcoming events
🔔 Earnings release
The next release date has not been announced yet.
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 3월 25일 (수) · 장 시작 전

Is it profitable?

Profitability weak
Profitability — How efficiently it makes money
ROA
Annual earnings relative to total company assets
-29.5%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Financial health — Debt & liquidity burden
Current Ratio
Liquid assets available to cover liabilities due within a year
1.09
✓ 평균
My positionMid-range
Low range Average High range
Biotechnology Median 5.75
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
1.09
✓ 양호
My positionMid-range
Low range Average High range
Biotechnology Median 5.47
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$1.25
현재가 대비 +6.8%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Average Growth
Mid-range within the industry
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+38.5%
양호
My positionMid-range
Low range Average High range
방어주 초소형주 Median 30.0% · Top 43%
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
+37.3%
양호
My positionMid-range
Low range Average High range
방어주 초소형주 Median 16.4% · Top 32%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Long-term weakness — -156%p below the market
BYSI -87.4% · S&P 500 +68.3%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-155.7%p
Significantly behind the market
vs Health Care (XLV)
-111.9%p
Significantly behind the sector average
1-year basis
vs S&P 500
-55.1%p
Significantly behind the market
vs Health Care (XLV)
-58.8%p
Significantly behind the sector average
Rank among peers
5-year return Top 25% Based on 245 peers
1-year return Upper-Mid (44%) Based on 315 peers
Current position within 52-week range
Low (-17.7%p) High (-52.0%p)
Current price is 17.7% above the 52-week low and 52.0% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-42.2%
Annualized volatility
69.8%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴
Current diagnosis · 2026-07-27
Downtrend zone

Current price $1.17 below the midline ($1.44). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🔴
Current diagnosis · 2026-07-27
Bearish momentum holding

MACD -0.135 < Signal -0.103 in negative zone + Hist negative (-0.032). Weakness in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-27
Bearish zone

RSI 33.0 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 24.7.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Valuation data is insufficient

Key metrics such as PER and PBR are unavailable, so valuation is omitted.

Who owns it?

Ownership flow shows some pressure
Institutional net selling -1.4% · Short interest moderate 7.1%
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
0.0%
Insiders little change
🏦 Institutions (funds & investors)
-1.4%
Institutions net selling
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 5.3%
Retail-led
Healthcare 초소형주 Median 14.2%
🧑‍💼 Insiders 24.1%
Founder/management large holders (strong skin-in-the-game)
Healthcare 초소형주 Median 16.1%
👤 Retail investors (estimated) 70.5%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
7.1%
Moderate
Healthcare 초소형주 Median 3.9%
Past 90 days Little change
Short interest days to cover
90.7 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 41.1M주
Float (tradable shares) 31.2M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding BYSI

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
BYSI BYSI This Stock
$48.1M- - - - +4.5%
LLY
$1.13T43.1 36.2 107.64% 0.58% +0.1%
JNJ
$640.9B30.8 7.5 25.74% 2.02% +1.0%
ABBV
$453.9B126.7 - 15221.82% 2.67% -0.9%
UNH
$379.3B26.9 3.9 12.49% 2.16% -0.7%
MRK
$323.0B36.8 7.0 18.97% 2.5% -0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of company is 비욘드스프링(BYSI)?

비욘드스프링(BYSI) belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of BYSI?

The market cap of BYSI is approximately $48M, ranking 4,935 within its sector.

What is the 52-week high and low for BYSI?

BYSI has recorded a 52-week high of $2.44 and a low of $0.99.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.